← Back to Search

Cannabinoid

Cannabidiol for Healthy Subjects

N/A

Recruiting

Research Sponsored by University of Northern Colorado

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10-25 minutes

Awards & highlights

Study Summary

This trial aims to investigate if CBD can help reduce anxiety and gut distress in female athletes, potentially improving their running performance.

Who is the study for?

This trial is for moderately active individuals who identify as female and are interested in how CBD might affect their two-mile run performance. Participants should be healthy with no major medical issues.Check my eligibility

What is being tested?

The study is testing the effects of CBD capsules on running performance, specifically looking at anxiety levels, gut distress during endurance activities, and overall two-mile run times.See study design

What are the potential side effects?

Potential side effects of CBD may include mild drowsiness, dry mouth, lightheadedness, and low blood pressure. Some people might also experience changes in mood or appetite.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10-25 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10-25 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-25 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in Anxiety Measured with the State Trait Anxiety Inventory

Difference in Blood Lactate Concentrations

Difference in Gastrointestinal Distress

+2 more

Side effects data

From 2015 Phase 3 trial • 120 Patients • NCT02091375

31%

Diarrhoea

31%

Somnolence

26%

Decreased appetite

18%

Fatigue

15%

Vomiting

15%

Pyrexia

11%

Upper respiratory tract infection

11%

Lethargy

Convulsion

Weight decreased

Gamma-glutamyltransferase increased

Irritability

Cough

Transaminases increased

Status epilepticus

Nasopharyngitis

Pneumonia

Oral herpes

Platelet count

Abdominal distension

Abdominal pain

Gastrointestinal haemorrhage

Asthenia

Lower respiratory tract infection

Gamma-glutamyltransferase

Hypophagia

Hypotonia

Myoclonus

Respiratory failure

Epistaxis

Hypovolaemic shock

Aspartate aminotransferase increased

Liver function test abnormal

Headache

100%

80%

60%

40%

20%

Study treatment Arm

Placebo

GWP42003-P 20 mg/kg/Day Dose

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: CannabidiolExperimental Treatment1 Intervention

Cannabidiol capsules 2 hours prior to 2 mile run.

Group II: PlaceboPlacebo Group1 Intervention

Placebo capsules 2 hours prior to 2 mile run.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Northern ColoradoLead Sponsor

4 Previous Clinical Trials

337 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for potential participants in this research study?

"According to the information available on clinicaltrials.gov, patient recruitment is currently ongoing for this trial. The initial posting of the clinical trial was made on 11/11/2023, with the most recent update occurring on 4/11/2024."

Answered by AI

Is there an age limit for participation in this study, particularly with regard to individuals under 35 years old?

"To be eligible to participate in this clinical trial, individuals must be at least 18 years old but no older than 50."

Answered by AI

What is the current number of participants being enrolled in this clinical research study?

"Indeed, the details on clinicaltrials.gov confirm that this research project is actively seeking volunteers. Initially listed on November 11th, 2023, and most recently revised on April 11th, 2024, the study aims to enroll around 30 participants from a single designated site."

Answered by AI

Which individuals meet the necessary criteria to be eligible for participation in this medical study?

"To qualify for this study, individuals must be in good health and aged between 18 to 50 years. The trial aims to enroll approximately 30 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of CBD on 2 Mile Run Time Trial Performance

Laura Stewart 2023. "Effects of CBD on 2 Mile Run Time Trial Performance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06364254.

All > Cbd > Denver